Selected Publications

Lee, S.P., R.J. Tierney, W.A. Thomas, J.M. Brooks and A.B. Rickinson, 1997. Conserved CTL epitopes within EBV latent membrane protein 2; a potential target for CTL-based tumour therapy. J. Immunol. 158: 3325-3334.

Blake, N.W., S.P. Lee, I. Radchenko, W. Thomas, N. Steven, A. Leese, P. Steigerwald-Mullen, M.G. Kurilla, L. Frappier and A.B. Rickinson. 1997. Human CD8+ T cell responses to Epstein-Barr virus EBNA 1: HLA class i presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 7: 791-802.

Lee, S.P., C.M. Constandinou, W.A. Thomas, D. CroomCarter, N.W. Blake, P.G. Murray, J. Crocker and A.B. Rickinson. 1998. Antigen presenting phenotype of Hodgkin Reed-Sternberd cells: Analysis of the HLA class I processing pathway and the effects of interleukin-10 on Epstein-Barr virus-specific cytotoxic T-cell recognition. Blood 92: 1020-1030.

Lee, S.P., S.T. Cheung, A.T.C. Chan, W.A. Thomas, D. CroomCarter, S.F. Leung, P.J. Johnson and D. Huang.2000. CTL control of EBV in Nasopharyngeal Carcinoma (NPC): EBV-specific CTL responses in the blood and tumours of NPC patients and the antigen-processing function of the tumour cells. J. Immunol. 165: 573-582.

Chapman, A.L.N., A.B. Rickinson, W.A. Thomas, R.F. Jarrett, J. Crocker and S.P. Lee. 2001. Epstein-Barr virus-specific Cytotoxic T Lymphocyte responses in the blood and tumour site of Hodgkin's Disease patients: Implications for a T Cell-based therapy. Cancer Research 61:6219-6226.